BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20650876)

  • 1. From bone biology to clinical outcome: state of the art and future perspectives.
    Schett G; Saag KG; Bijlsma JW
    Ann Rheum Dis; 2010 Aug; 69(8):1415-9. PubMed ID: 20650876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Still a blind spot for osteoporosis prevention and treatment for rheumatoid arthritis.
    Jolles BM; Bogoch ER
    J Rheumatol; 2004 Apr; 31(4):822; author reply 822-3. PubMed ID: 15095736
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiology of osteoporosis in rheumatic diseases.
    Sinigaglia L; Varenna M; Girasole G; Bianchi G
    Rheum Dis Clin North Am; 2006 Nov; 32(4):631-58. PubMed ID: 17288969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specialties in therapy of osteoporosis in inflammatory joint disease].
    Franck H; Braun J; Buttgereit F; Dreher R; Hein G; Kekow J
    Z Rheumatol; 2004 Jun; 63(3):223-9. PubMed ID: 15224226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatic disorders and glucocorticoid-induced osteoporosis.
    Dequeker J; Westhovens R; Luyten FP
    Front Horm Res; 2002; 30():107-20. PubMed ID: 11892257
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH; Katz JN; Jacobs JP; La Tourette AM; Coblyn J
    Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The risk of developing osteoporosis in rheumatic diseases].
    Dequeker J; Vertraeten A; Gevers D; Geusens P
    Klin Med (Mosk); 1989 Jul; 67(7):116-9. PubMed ID: 2811200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone changes in early rheumatoid arthritis.
    Green MJ; Deodhar AA
    Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):105-23. PubMed ID: 11358418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.
    Zhang Y; Milojevic D
    Paediatr Drugs; 2017 Jun; 19(3):193-211. PubMed ID: 28290112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal complications of rheumatoid arthritis.
    Heinlen L; Humphrey MB
    Osteoporos Int; 2017 Oct; 28(10):2801-2812. PubMed ID: 28779302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathologic condition of osteoporosis in rheumatoid arthritis].
    Suwa A; Saito E; Wakabayashi T; Suzuki Y
    Clin Calcium; 2007 Aug; 17(8):1262-6. PubMed ID: 17660625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis.
    Daoussis D; Andonopoulos AP; Liossis SN
    Semin Arthritis Rheum; 2010 Apr; 39(5):369-83. PubMed ID: 19095294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy in pregnancy and lactation in rheumatic diseases].
    Anić B; Cikes N
    Reumatizam; 2006; 53(2):55-8. PubMed ID: 17580555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
    Wang QH; Wu HX; Huang YL; Xue J; Yang XY; Zhu L; Wen LH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1888-91. PubMed ID: 19040000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary osteoporosis. A review of recent evidence focusing on glucocorticoid-induced osteoporosis and osteoporosis associated with rheumatoid arthritis].
    Suzuki Y
    Clin Calcium; 2007 Jan; 17(1):104-7. PubMed ID: 17211102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic therapy with glucocorticoids. Treatment of rheumatic diseases].
    Möller B
    Pharm Unserer Zeit; 2003; 32(4):302-5. PubMed ID: 12899067
    [No Abstract]   [Full Text] [Related]  

  • 18. [Generalized osteoporosis in chronic polyarthritis--pathomechanisms and treatment approaches].
    Ringe JD
    Z Rheumatol; 1996; 55(3):149-57. PubMed ID: 8768144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation-induced bone loss: can it be prevented?
    Romas E; Gillespie MT
    Rheum Dis Clin North Am; 2006 Nov; 32(4):759-73. PubMed ID: 17288976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis in the rheumatic disease patient.
    Lane NE; Rehman Q
    Lupus; 2002; 11(10):675-9. PubMed ID: 12413067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.